Warsaw, Mazowieckie, Poland
I don't just grow businesses—I grow the people who grow businesses. My approach combines authentic leadership with strategic clarity to create sustainable growth that serves all stakeholders. Over two decades, I've specialized in the tough assignments. I've proven that purpose-driven organizations consistently outperform others. My philosophy is "love it, leave it, or change it"— just straight talk that builds trust and drives results. I focus on what matters most: giving people a reason to care and the tools to succeed. This cross-cultural bridge-building approach has taken me across five countries, each reinforcing that meaningful transformation happens when authentic leadership meets clear purpose. What energizes me most is unleashing human potential. Currently transforming Johnson & Johnson Poland, where we're proving that when you combine heart with hard business acumen, extraordinary results follow naturally. Because I believe the sky's the limit when transformation catalysts help others discover their potential.
Leading the Polish Johnson & Johnson Innovative Medicine commercial organization with full P&L responsibility . Member of the Greece, Poland, and Romania (GPR) Leadership Team.
Commercial Director Specialty Care is responsible for the Business Units Immunology (Dermatology, Rheumatology, Gastroenterology) and Neuroscience (Depression and MS) at Janssen Cilag GmbH in Germany, and Member of the Management Board at Janssen Cilag GmbH Germany
leading the cross functional Integrated Brand Value Team for the EMEA region (Europe, Middle East and Africa), developing and driving the strategic development of the dermatology portfolio, enabling and accelerating growth, strengthening market leadership & competitiveness for dermatology portfolio
Responsible for the global commercial strategic development of compounds either in early or late development. Driving the commercial conversation within the Compound Development Team to maximize patients benefits and further development specific compounds covering a high unmet medical need in prostate cancer. Aligning the Core Global Launch Strategy with the regional partners and proactively drive the Launch Readiness Roadmap together with the cross-functional Global Core Launch Team. Establishing close collaboration with external partners based on license agreement to guarantee an on-time global launch readiness. Depending on compound providing a hand-in-hand launch preparation with companion diagnostic partner.